Elsevier

Oral Oncology

Volume 40, Issue 1, January 2004, Pages 103-106
Oral Oncology

CASE REPORT
Primary B-cell lymphoma of the tongue in a patient with systemic sclerosis

https://doi.org/10.1016/S1368-8375(03)00137-4Get rights and content

Abstract

We report a patient with systemic sclerosis who had the unusual development of a large-cell B-cell lymphoma of the base of his tongue. Patients with systemic sclerosis display an increased incidence of malignant neoplasms, particularly, breast and lung carcinomas [Arthritis. Rheum. 36 (1993) 460; Ann. Rheum. Dis. 52 (1993) 531]. The description of this case adds further evidence to the possible interrelationship of systemic sclerosis and the development of malignant neoplasms. A careful review of the English medical literature disclosed that B-cell lymphoma of the tongue in a patient with systemic sclerosis is an association which has not been described previously.

Introduction

Inflammatory connective tissue disorders such as dermatomyositis, polymyositis and Sjögren's syndrome have been linked to an increased prevalence of malignant neoplasms.1, 2, 3 Early epidemiological studies in large cohorts of systemic sclerosis patients did not show an increased incidence of malignant neoplasias4 although more recent studies described a statistically significant excess of lung and breast neoplasms in patients with systemic sclerosis; the discrepancy being possibly related to improved screening for cancer.5, 6 In Sjögren's syndrome patients this increased risk appears to be almost exclusively related to the development of lymphoproliferative malignancies, and more specifically, to non-Hodgkin's lymphoma of the salivary glands.2 Increased risk of developing lymphoproliferative malignancies was also described in patients with rheumatoid arthritis, although in these patients it appears that either the use of certain disease modifying anti-rheumatic agents such as methotrexate or the presence of an undiagnosed secondary Sjögren's syndrome may be responsible.3 Lymphoproliferative disorders have been associated less frequently with systemic sclerosis and in large epidemiological studies the absolute incidence of these malignant neoplasms does not appear to be different from that in the general population.4, 5, 6

We report herein a patient with systemic sclerosis, who 2 years after this diagnosis, developed an expanding oral mass found to be a primary large-cell B-cell lymphoma of the tongue. This report describes this previously unreported rare association.

Section snippets

Case report

A 66-year-old Caucasian male developed Raynaud's phenomenon 4 years prior to the current presentation. Three years later he noticed puffiness of his hands, pruritus, worsening of Raynaud's symptoms and fingertip digital ulcerations. An evaluation revealed a positive antinuclear antibody (ANA) test on Hep-2 cell substrate with a titer of 1:1280 and a homogeneous pattern. An ELISA anti-topoisomerase-I (anti-Scl-70) antibody test was positive, while an anti-kinetochore (anti-centromere) antibody

Discussion

The majority of large cell lymphomas (>90%) are of B-cell origin and they comprise approximately 30–40% of all cases of non-Hodgkin's lymphomas.8, 9 The head and neck region is the second most frequent site of localized extranodal presentation of non-Hodgkin's lymphoma. Lymphomas of the Waldeyer's ring, which includes the tonsils, nasopharynx, base of tongue, larynx and hypolarynx are thought to be nodal in origin.10 Only 5.2% of head and neck lymphomas present at the base of the tongue,11 and

Acknowledgements

Supported by NIH Grant AR19616. Dr. Derk was supported by NIH Training Grant AR07583.

References (15)

  • R Otter et al.

    Primary extranodal and nodal non-Hodgkin's lymphoma: a survey of a population-based registry

    Eur J Cancer Clin Oncol

    (1989)
  • B Sigurgeirsson et al.

    Risk of cancer in patients with dermatomyositis and polymyositis

    N Engl J Med.

    (1992)
  • P Zufferey et al.

    Primary Sjögren's syndrome and malignant lymphoma. A retrospective cohort study of 55 patients with SS

    Scand J Rheumatol

    (1995)
  • H.A Isomaki et al.

    Excess risk of lymphoma, leukemia and myeloma in patients with rheumatoid arthritis

    Ann Rheum Dis

    (1982)
  • D.L Tuffanelli et al.

    Systemic sclerodermaa clinical study of 727 cases

    Arch Dermatol

    (1961)
  • M Abu Shakra et al.

    Cancer in systemic sclerosis

    Arthritis Rheum

    (1993)
  • A.K Rosenthal et al.

    Scleroderma and malignancyan epidemiological study

    Ann Rheum Dis

    (1993)
There are more references available in the full text version of this article.

Cited by (12)

  • Malignancies associated with systemic sclerosis

    2012, Autoimmunity Reviews
    Citation Excerpt :

    Regarding lymphoproliferative disorders, B-cell lymphoma is possibly the most common type due to chronic B-cell stimulation associated with the pathogenesis of SSc [10,20]. Several cases of B-cell NHL, chronic lymphocytic leukemia (B-CLL) and gastrointestinal MALT lymphoma have been reported [10,20,22,23]. Our group presented three cases of malignant B-cell lymphoma associated with SSc [10].

  • Prevalence of oral and maxillofacial disorders in patients with systemic scleroderma—a systematic review

    2021, International Journal of Environmental Research and Public Health
View all citing articles on Scopus
View full text